Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Li Hsieh

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Investigative and Clinical Urology|September 6, 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancerChung-Lin Lee, Ying-Hsu Chang, Chung-Yi Liu, et al.
Clinical Interventions in Aging|December 16, 2024
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser ProstatectomyPo-Han Chen, Ruei-Je Chang, Hsiang-Sheng Wang, et al.
Frontiers in Oncology|August 28, 2023
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumorLiang-Kang Huang, Yu-Ching Lin, Hai-Hua Chuang, et al.
Cancers|February 25, 2023
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder CancerPo-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, et al.
Oncology Letters|August 22, 2024
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancerI-Hung Shao, Tzu-Hsuan Chang, Ying-Hsu Chang, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Investigative and Clinical Urology|September 6, 2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancerChung-Lin Lee, Ying-Hsu Chang, Chung-Yi Liu, et al.
Clinical Interventions in Aging|December 16, 2024
Impact of Obesity on Clinical Presentation and Surgical Outcomes in Patients with Benign Prostate Hyperplasia Receiving Greenlight Laser ProstatectomyPo-Han Chen, Ruei-Je Chang, Hsiang-Sheng Wang, et al.
Frontiers in Oncology|August 28, 2023
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumorLiang-Kang Huang, Yu-Ching Lin, Hai-Hua Chuang, et al.
Cancers|February 25, 2023
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder CancerPo-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, et al.
Oncology Letters|August 22, 2024
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancerI-Hung Shao, Tzu-Hsuan Chang, Ying-Hsu Chang, et al.
Pageof 5